On 15 June 2015, Prosonix was acquired by Circassia Pharmaceuticals plc creating a world-class allergy and asthma specialty biopharma business

For more information on Circassia, please go to www.circassia.com

Latest News
May 15, 2015
Prosonix enters Definitive Agreement to be acquired by Circassia Pharmaceuticals plc for up to £100 million in Cash
Sep 11, 2014
Prosonix Confirms the Potential of its Multi-Component Particle™ Technology for Developing Novel Inhaled Dual...
Sep 2, 2014
Prosonix’ Marketing Authorisation Application for PSX1001 – a Generic Version of GlaxoSmithKline’s Flixotide®...
Terms & Conditions
© Prosonix Ltd, 2016
The Medawar Centre   Robert Robinson Avenue   Oxford Science Park   Oxford   OX4 4GA   United Kingdom   |   Tel: +44 (0)1865 784250   |   Email: Here